Monoclonal antibody against DOG1 protein and cell strain, preparation method and application thereof
A monoclonal antibody, hybridoma cell line technology, applied in the field of biomedical engineering, can solve the problem of less research on DOG1 protein and achieve high specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Embodiment 1 Preparation of recombinant DOG1 protein fragment
[0023] 1. Gene optimization and synthesis
[0024] According to the protein sequence with the accession number Q5XXA6 in the Uniprot database, DOG1 selects a protein fragment with 53-291 amino acid residues, and directly optimizes it into a gene fragment suitable for expression in Escherichia coli BL21 (DE3). During the PCR process, EcoR I and XhoI restriction sites were added to the 5' and 3' ends of the gene, respectively.
[0025] The PCR product was separated by agarose gel electrophoresis and recovered. The recovered fusion protein gene and the plasmid vector Pet30a used for expression were digested with EcoRI and XhoI respectively, recovered by electrophoresis again, and ligated with T4 DNA ligase. The ligation product was transformed into Escherichia coli competent cell BL21(DE3), and the clones on the plate were picked and inoculated, and the bacteria liquid PCR was identified. Clones with positiv...
Embodiment 2
[0030] The establishment of embodiment 2 hybridoma cell lines
[0031] 1. Immunity
[0032] The cross-linked polypeptide in Example 1 was emulsified with complete Freund's adjuvant (Sigma, F5881), and immunized with 4-6 week-old female ICR mice (purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.), subcutaneously in the abdomen. Inject each mouse at 6 points with a dose of 60 μg / mouse. Immunization was boosted once every 14 days, and the antigen was emulsified with Freund's incomplete adjuvant (Sigma Company, F5506) at a dose of 30 μg per mouse. 7 days after the third booster immunization, indirect ELISA (wavelength 450nm) was used to detect the polyantibody titer of the anti-immunogen in the mouse serum. 50μg / only.
[0033] 2. Cell Fusion
[0034]Aseptically prepare the mouse splenocyte suspension that reaches the immune standard, mix it with mouse myeloma cell sp2 / 0 (ATCCNumberCRL-8287) at a ratio of 5:1, and centrifuge at 1500rpm for 5min. Aft...
Embodiment 3
[0037] Example 3 Preparation of Monoclonal Antibody by Ascites Induction Method
[0038] 1. Ascites preparation
[0039] The cells in the logarithmic growth phase were washed with serum-free medium and suspended, counted about 5×10 5 , 1ml. The suspended cells were injected intraperitoneally into mice previously sensitized with paraffin oil. Ascites collection was started 7 days later. The removed ascites was centrifuged at 4000rpm for 10min at 4°C. Carefully suck out the ascites in the middle and collect in a centrifuge tube, and store at 4°C or -20°C.
[0040] 2. Purification of monoclonal antibodies
[0041] Antibody was purified from ascitic fluid by HiTrap rProtein A FF (GE Company) affinity chromatography according to the manual. The purity was identified by SDS-PAGE gel, and the concentration was determined by Bradford method. Purified antibodies were stored at -20°C.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com